The regulator put group health as an option on a list that also included short-term health insurance and direct primary care arrangements.
This is going to be a fundamental shift in the program, because we’re going to move away from that upfront discount program to a post-purchase rebate,” said Dr. Urshlila Shah, former chief pharmacy ...
The Employee Benefits Security Administration can still draft broker comp disclosure rules and enforce group health mental parity rules.
Melissa discusses the crucial need for effective, culturally sensitive benefits translation and communication, as well as why ...
Despite proving at trial that the airline favored ESG goals in its 401(k) plan, the plaintiff failed to show that this resulted in financial losses, according to Judge Reed O’Conner of the U.S.
We have seen a surge in federal agency enforcement, new rulemaking and litigation, as well as ongoing state developments that both challenge and reinforce these federal efforts,” Laura Hancock, ERISA ...
Benefits professionals must not only react to high-cost claims, but recognize red flags early and implement cost containment strategies before those claims escalate.
"Congress must act as quickly as possible to extend the health care tax credits," AHIP said in a commentary posted today. "If Congress fails to extend the tax credits, small businesses may be forced ...
Only 15% of people are willing to cut back on financial support, even if it means skipping medical care, delaying repairs, or lowering their standard of living.
Two-thirds of employers and a majority of workers value these benefits, and sales of both products rebounded in the second quarter of this year.
Cancer care is a major contributor to soaring employer health care costs. Eighty-six percent of employers say their cancer care spend has increased since last year by a median rate of 11%, a new ...
The U.S. health care system has a remarkable track record of creating breakthrough medicines and treatments. But that same innovation has fueled unsustainable costs, including for specialty biologics ...